Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001848498 | SCV002105303 | uncertain significance | Hereditary spastic paraplegia | 2020-01-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002545272 | SCV002974285 | uncertain significance | Spastic ataxia 2 | 2022-07-03 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1344395). This variant has not been reported in the literature in individuals affected with KIF1C-related conditions. This variant is present in population databases (rs760659714, gnomAD 0.002%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 615 of the KIF1C protein (p.Pro615Leu). |